Ex vivo PBMC cytokine profile in familial Mediterranean fever patients: Involvement of IL-1β, IL-1α and Th17-associated cytokines and decrease of Th1 and Th2 cytokines

Cytokine

Volumn 69, Issue 2, 2014, Pages 248-254

  Ibrahim, José Noel ^a,b   Jounblat, Rania ^a   Delwail, Adriana ^b   Abou Ghoch, Joelle ^c   Salem, Nabiha ^c   Chouery, Eliane ^c   Megarbane, André ^c   Medlej Hashim, Myrna ^a   Lecron, Jean Claude ^b  

^a LEBANESE UNIVERSITY   (Lebanon)

^b Material Sciences   (France)

^c SAINT JOSEPH UNIVERSITY   (Lebanon)

Author keywords

Cytokine; Ex vivo; FMF; Inflammasome; PBMC

Indexed keywords

CD3 ANTIBODY; COLCHICINE; GAMMA INTERFERON; INFLAMMASOME; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 22; INTERLEUKIN 4; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; ACUTE PHASE PROTEIN; CYTOSKELETON PROTEIN; MARENOSTRIN;

ADULT; ARTICLE; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EX VIVO STUDY; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HOMOZYGOTE; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; INFLAMMATION; MALE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; REMISSION; SUPERNATANT; T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL; BLOOD; CASE CONTROL STUDY; DRUG EFFECTS; GENETICS; METABOLISM; MONONUCLEAR CELL;

ACUTE-PHASE PROTEINS; ADULT; CASE-CONTROL STUDIES; CYTOSKELETAL PROTEINS; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMANS; INTERLEUKIN-1ALPHA; INTERLEUKIN-1BETA; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MALE; MONOCYTES; TH1 CELLS; TH17 CELLS; TH2 CELLS;

EID: 84904135119     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2014.06.012     Document Type: Article

References (47)

1. Sohar E., Gafni J., Pras M., et al. Familial Mediterranean fever: a survey of 470 cases and review of the literature. Am J Med 1967, 43:227-253.
2. Ben-Chetrit E., Levy M. Familial Mediterranean fever. Lancet 1998, 351:659-664.
3. Medlej-Hashim M., Loiselet J., Lefranc G., et al. Familial Mediterranean fever (FMF): from diagnosis to treatment. Sante 2004, 14:261-266.
4. Centola M., Wood G., Frucht D.M., et al. The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to in inflammatory mediators. Blood 2000, 95:3223-3231.
5. Chae J.J., Wood G., Masters S.L., et al. The B30.2domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production. Proc Natl Acad Sci USA 2006, 103:9982-9987.
6. Papin S., Cuenin S., Agostini L., et al. The SPRY domain of Pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1beta processing. Cell Death Differ 2007, 14:1457-1466.
7. Yu J.W., Wu J., Zhang Z., et al. Cryopyrin and pyrin activate caspase-1, but not NF-kappaB, via ASC oligomerization. Cell Death Differ 2006, 13:236-249.
8. Chae J.J., Cho Y.H., Lee G.S., et al. Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1β activation and severe autoinflammation in mice. Immunity 2011, 34:755-768.
9. Omenetti A., Carta S., Delfino L., et al. Increased NLRP3-dependent interleukin 1β secretion in patients with familial Mediterranean fever: correlation with MEFV genotype. Ann Rheum 2014, 73:462-469.
10. Dinarello C.A. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 2011, 117:3720-3732.
11. Wilson N.J., Boniface K., Chan J.R., et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007, 8:950-957.
12. Chung Y., Chang S.H., Martinez G.J., et al. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 2009, 30:576-587.
13. Cooney L.A., Towery K., Endres J., et al. Sensitivity and resistance to regulation by IL-4 during Th17 maturation. J Immunol 2011, 187:4440-4450.
14. Bagci S., Toy B., Tuzun A., et al. Continuity of cytokine activation in patients with familial Mediterranean fever. Clin Rheumatol 2004, 23:333-337.
15. Musabak U., Sengül A., Oktenli C., et al. Does immune activation continue during an attack-free period in familial Mediterranean disease?. Clin Exp Immunol 2004, 138:526-533.
16. Tsutsumi A., Takahashi R., Sumida T. Mannose binding lectin: genetics and autoimmune disease. Autoimmun Rev 2005, 4:364-372.
17. Kaur S., Gupta V.K., Shah A., et al. Elevated levels of mannan-binding leptin (MBL) and eosinophilia in patients of bronchial asthma with allergic rhinitis and allergic bronchopulmonary aspergillosis associate with a novel intronic polymorphism in MBL. Clin Exp Immunol 2006, 143:414-419.
18. Schafranski M.D., Stier A., Nisihara R., et al. Significantly increased levels of mannose-binding lectin (MBL) in rheumatic heart disease: a beneficial role for MBL deficiency. Clin Exp Immunol 2004, 138:521-525.
19. Manukyan G.P., Ghazaryan K.A., Ktsoyan Zh.A., et al. Cytokine profile of Armenian patients with familial Mediterranean fever. Clin Biochem 2008, 41:920-922.
20. Simsek I., Pay S., Pekel A., et al. Serum proinflammatory cytokines directing T helper 1 polarization in patients with familial Mediterranean fever. Rheumatol Int 2007, 27:807-811.
21. Erken E., Ozer H.T., Gunesacar R. Plasma interleukin-10 and interleukin-12 levels in patients with familial Mediterranean fever. Rheumatol Int 2006, 26:862-864.
22. Haznedaroglu S., Oztürk M.A., Sancak B., et al. Serum interleukin 17 and interleukin 18 levels in familial Mediterranean fever. Clin Exp Rheumatol 2005, 23:S77-S80.
23. Oktem S., Yavuzsen T.U., Sengul B., et al. Levels of interleukin-6 (IL-6) and its soluble receptor (sIL-6R) in familial Mediterranean fever (FMF) patients and their first degree relatives. Clin Exp Rheumatol 2004, 22:S34-S36.
24. Baykal Y., Saglam K., Yilmaz M.I., et al. Serum sIL-2r, IL-6, IL-10 and TNF-alpha level in familial Mediterranean fever patients. Clin Rheumatol 2003, 22:99-101.
25. Köklü S., Öztürk M.A., Balci M., et al. Interferon-gamma levels in familial Mediterranean fever joint bone. Spine 2005, 72:38-40.
26. Heller H., Sohar E., Sherf L. Familial Mediterranean fever. Arch Intern Med 1958, 102:50-56.
27. The French FMF Consortium A candidate gene for familial Mediterranean fever. Nat Genet 1997, 17:25-31.
28. The International FMF Consortium Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 1997, 90:797-807.
29. Jéru I., Hentgen V., Normand S., et al. Role of interleukin-1β in NLRP12-associated autoinflammatory disorders and resistance to anti-interleukin-1 therapy. Arthritis Rheum 2011, 63:2142-2148.
30. Pascual V., Allantaz F., Arce E., et al. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med 2005, 201:1479-1486.
31. Drenth J.P., Van Deuren M., Van der Ven-Jongekrijg J., et al. Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Blood 1995, 85:3586-3593.
32. Korkmaz C., Ozdogan H., Kasapcopur O., et al. Acute phase response in familial Mediterranean fever. Ann Rheum Dis 2002, 61:79-81.
33. Lachmann H.J., Sengul B., Yavuzsen T.U., et al. Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV muations. Rheumatology 2006, 45:746-750.
34. Drenth J.P., van der Meer J.W., Kushner I. Unstimulated peripheral blood mononuclear cells from patients with the hyper-IgD syndrome produce cytokines capable of potent induction of C-reactive protein and serum amyloid A in Hep3B cells. J Immunol 1996, 157:400-404.
35. Notarnicola C., Didelot M.N., Seguret F., et al. Enhanced cytokine mRNA levels in attack-free patients with familial Mediterranean fever. Genes Immun 2002, 3:43-45.
36. Zhou X., Fragala M.S., McElhaney J.E., et al. Conceptual and methodological issues relevant to cytokine and inflammatory marker measurements in clinical research. Curr Opin Clin Nutr Metab Care 2010, 13:541-547.
37. Goldbach-Mansky R., Dailey N.J., Canna S.W., et al. Neonatal-onset multisystem inflammatory disease responsive to interleukin-1 inhibition. N Engl J Med 2006, 355:581-592.
38. Gattorno M., Tassi S., Carta S., et al. Pattern of interleukin-1 secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations. Arthritis Rheum 2007, 56:3138-3148.
39. Fettelschoss A., Kistowska M., LeibundGut-Landmann S., et al. Inflammasome activation and IL-1β target IL-1α for secretion as opposed to surface expression. Proc Natl Acad Sci USA 2011, 108:18055-18060.
40. Kastner D.L. Familial Mediterranean fever: the genetics of inflammation. Hosp Pract 1998, 33:131-134. [139-40, 143-6 passim].
41. Ovadia A., Livneh A., Feld O., et al. T helper 17 polarization in familial Mediterranean fever. Genes Immun 2013, 14:212-216.
42. Miossec P., Korn T., Kuchroo V.K. Interleukin-17 and type 17 helper T cells. N Engl J Med 2009, 361:888-898.
43. O'Connor W., Zenewicz L.A., Flavell R.A. The dual nature of TH17 cells: shifting the focus to function. Nat Immunol 2010, 11:471-476.
44. Zenewicz L.A., Yancopoulos G.D., Valenzuela D.M., et al. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 2008, 29:947-957.
45. Rimar D., Rosner I., Slobodin N., et al. The role of regulatory T cells in familial Mediterranean fever (FMF). Clin Rheumatol 2012, 31:885-888.
46. Medlej-Hashim M., Delague V., Chouery E., et al. Amyloidosis in familial Mediterranean fever patients: correlation with MEFV genotype and SAA1 and MICA polymorphisms effects. BMC Med Genet 2004, 5:4.
47. Medlej-Hashim M., Petit I., Adib S., et al. Familial Mediterranean fever: association of elevated IgD plasma levels with specific MEFV mutations. Eur J Hum Genet 2001, 9:849-854.